$33.30—Stale · unknown old
NYSE • Last print unknown ago
$33.30—Stale · unknown old
iShares Health Innovation Active ETF (BMED) focuses on investments in companies driving innovation in the healthcare sector, including biotechnology, pharmaceuticals, and healthcare technology. The ETF's strategy is to capitalize on growth opportunities in the health innovation space, primarily in the U.S. and developed markets.
BMED generates revenue primarily through management fees based on the assets it manages. The ETF's active management approach allows it to capitalize on market inefficiencies and invest in companies with strong growth potential in the healthcare sector, providing a competitive edge over passive funds.
Performance of underlying healthcare stocks, particularly biotech and pharma
Changes in healthcare regulations and policies
Market sentiment towards health innovation trends
Interest rate fluctuations impacting investment flows
Regulatory changes affecting healthcare funding and reimbursement
Technological disruption in healthcare delivery and innovation
Increased competition from other actively managed healthcare ETFs
Market share loss to lower-cost passive investment vehicles
Liquidity risks associated with rapid redemptions during market downturns
Potential impact of rising operational costs on expense ratios
moderate - The healthcare sector is generally resilient during economic downturns, but growth in health innovation can be influenced by overall consumer spending and investment trends.
Rising interest rates can lead to higher financing costs for healthcare companies, potentially impacting their growth and profitability, which in turn affects the ETF's performance and valuation multiples.
minimal - The ETF is not heavily reliant on credit markets, but broader credit conditions can influence investor sentiment and flows into equity markets.
growth - Investors seeking exposure to innovative healthcare companies with high growth potential.
moderate - The ETF's performance can be volatile due to the nature of the underlying healthcare stocks.